Publications

Found 1 results
Filters: Author is R.A. Toledo  [Clear All Filters]
2012
U. Camargo, Toledo, R. A., Cintra, J. R., Nunes, D. P. T., R. de Toledo, A., de Mattos, C. C. Brandão, and Mattos, L. C., Lack of association of the G22A polymorphism of the ADA gene in patients with ankylosing spondylitis, vol. 11, pp. 1178-1184, 2012.
Bottini E, Carapella E, Cataldi L, Nicotra M, et al. (1981). Adenosine deaminase polymorphism. Associations at clinical level suggest a role in cell functions and immune reactions. J. Med. Genet. 18: 331-334. http://dx.doi.org/10.1136/jmg.18.5.331 PMid:7199090 PMCid:1048752   Breban M (2006). Genetics of spondyloarthritis. Best Pract. Res. Clin. Rheumatol. 20: 593-599. http://dx.doi.org/10.1016/j.berh.2006.03.002 PMid:16777584   Brionez TF and Reveille JD (2008). The contribution of genes outside the major histocompatibility complex to susceptibility to ankylosing spondylitis. Curr. Opin. Rheumatol. 20: 384-391. http://dx.doi.org/10.1097/BOR.0b013e32830460fe PMid:18525349   Dutra GP, Ottoni GL, Lara DR and Bogo MR (2010). Lower frequency of the low activity adenosine deaminase allelic variant (ADA1*2) in schizophrenic patients. Rev. Bras. Psiquiatr. 32: 275-278. http://dx.doi.org/10.1590/S1516-44462010005000003 PMid:20414589   Goie HS, Steven MM, Van der Linden SM and Cats A (1985). Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Rheumatology 24: 242-249. http://dx.doi.org/10.1093/rheumatology/24.3.242   Hirschhorn R, Yang DR and Israni A (1994). An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann. Hum. Genet. 58: 1-9. http://dx.doi.org/10.1111/j.1469-1809.1994.tb00720.x PMid:8031011   Lima I, Néri F and Santiago MB (2005). Dosagem sérica de adenosina deaminase em lúpus eritematoso sistêmico: ausência de associação com atividade da doença. Rev. Bras. Reumatol. 45: 273-279. http://dx.doi.org/10.1590/S0482-50042005000500002   Liu Y, Saccucci P, Qi H, Wu HC, et al. (2006). ADA polymorphisms and asthma: a study in the Chinese Han population. J. Asthma 43: 203-206. http://dx.doi.org/10.1080/02770900600566827 PMid:16754522   Lopez de Castro JA (2007). HLA-B27 and the pathogenesis of spondyloarthropathies. Immunol. Lett. 108: 27-33. http://dx.doi.org/10.1016/j.imlet.2006.10.004 PMid:17129613   Nunes DP, Spegiorin LC, de Mattos CC, Oliani AH, et al. (2011). The ADA*2 allele of the adenosine deaminase gene (20q13.11) and recurrent spontaneous abortions: an age-dependent association. Clinics 66: 1929-1933. http://dx.doi.org/10.1590/S1807-59322011001100013 PMid:22086524 PMCid:3203966   Saccucci P, Manca Bitti ML, Bottini N, Rapini N, et al. (2009). Type 1 diabetes: evidence of interaction between ACP1 and ADA1 gene polymorphisms. Med. Sci. Monit. 15: CR511-CR517. PMid:19789510   Saccucci P, Meloni GF, Verrotti A, Borgiani P, et al. (2010). A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 23: 283-290. http://dx.doi.org/10.1515/JPEM.2010.23.3.283 PMid:20480728   Safranow K, Rzeuski R, Binczak-Kuleta A, Czyzycka E, et al. (2007). ADA*2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology 108: 275-281. http://dx.doi.org/10.1159/000099096 PMid:17287605   Sampaio-Barros PD, Azevedo VF, Bonfiglioli R, Campos WR, et al. (2007). Consenso Brasileiro de Espondiloartropatias: Espondilite Anquilosante e Artrite Psoriásica Diagnóstico e Tratamento - Primeira Revisão. Rev. Bras. Reumatol. 47: 233-242. http://dx.doi.org/10.1590/S0482-50042007000400001   Sari RA, Taysi S, Yilmaz O and Bakan N (2003). Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin. Exp. Rheumatol. 21: 87-90. PMid:12673895   Sasaki S (1984). Pathogenetic significance of adenosine deaminase in autoimmune diseases. Nihon Seikeigeka Gakkai Zasshi 58: 219-230. PMid:6332160   SEADE (2009). Fundação Sistema Estadual de Análise de Dados. Secretaria de Planejamento e Desenvolvimento Regional. Perfil Regional. Região Administrativa de São José do Rio Preto. Available at [http://www.seade.gov.br/produtos/perfil_regional/index.php]. Accessed March 30, 2011.   Sebastiani GD, Bottini N, Greco E, Saccucci P, et al. (2010). A study of Adenosine-Deaminase genetic polymorphism in rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 23: 791-795. PMid:20943049   Van der Linden S and Van der Heijde D (1998). Ankylosing spondylitis: clinical features. Rheum. Dis. Clin. North Am. 24: 663-676. http://dx.doi.org/10.1016/S0889-857X(05)70036-3   Wessels JA, Kooloos WM, De Jonge R, De Vries-Bouwstra JK, et al. (2006). Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 54: 2830-2839. http://dx.doi.org/10.1002/art.22032 PMid:16947783